[1]DeGraw;Colwell;Piper;Sirotnak[JournalofMedicinalChemistry,1993,vol.36,#15,p.2228-2231]
[2]CurrentPatentAssignee:CANAVESI;GALLUZZO;TEVAPHARMACEUTICALINDUSTRIESLTD.;TISENI;BILJAN-WO2013/96800,2013,A1
[3]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2014/68599,2014,A2Locationinpatent:Page/Pagecolumn8
[1]JournalofMedicinalChemistry,1993,vol.36,p.2228-2231
[2]Patent:US2011/190305,2011,A1
[3]Patent:WO2013/177713,2013,A1
[4]Patent:WO2014/16740,2014,A2
[5]Patent:WO2014/16740,2014,A2
[6]Patent:WO2014/68599,2014,A2
[7]Patent:US2015/183789,2015,A1
[8]Patent:US2015/183789,2015,A1
[1]CurrentPatentAssignee:LUNANPHARMACEUTICALGROUPCOLTD-CN108069970,2018,ALocationinpatent:Paragraph0028-0045
[2]CurrentPatentAssignee:EUROFINSSCIENTIFICSA-WO2013/177713,2013,A1Locationinpatent:Paragraph0077
[3]CurrentPatentAssignee:MEMORIALSLOAN-KETTERINGCANCERCENTER-US2005/267117,2005,A1Locationinpatent:Page/Pagecolumn3;4;Sheet2
[4]CurrentPatentAssignee:SPECTRUMPHARMACEUTICALSINC-US2011/190305,2011,A1Locationinpatent:Page/Pagecolumn7
[5]CurrentPatentAssignee:FRESENIUSSE&CO.KGAA-WO2014/20553,2014,A1Locationinpatent:Page/Pagecolumn9-10
[6]CurrentPatentAssignee:FRESENIUSSE&CO.KGAA-WO2014/16740,2014,A2Locationinpatent:Page/Pagecolumn25;26
[7]CurrentPatentAssignee:FRESENIUSSE&CO.KGAA-US2015/183789,2015,A1Locationinpatent:Paragraph0173;0174;0175;0176;0177;0178;0179;0180
[1]CurrentPatentAssignee:CANAVESI;GALLUZZO;TEVAPHARMACEUTICALINDUSTRIESLTD.;TISENI;BILJAN-WO2013/96800,2013,A1Locationinpatent:Paragraph00112
[1]CurrentPatentAssignee:AVRALABPRIVATE-WO2013/164856,2013,A1Locationinpatent:Page/Pagecolumn22
Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology 20150518
Title: Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma.
Journal: Expert opinion on pharmacotherapy 20130301
Title: Lack of expression of MTAP in uncommon T-cell lymphomas.
Journal: Clinical lymphoma, myeloma & leukemia 20121001
Title: Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study.
Journal: Clinical lymphoma, myeloma & leukemia 20120801
Title: Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20120801
Title: Cutaneous T-cell lymphoma's confounding nature.
Journal: Journal of the National Cancer Institute 20120606
Title: Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601
Title: Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120601
Title: Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Journal: Blood 20120503
Title: Clinical development of new formulations of cytotoxics in solid tumors.
Journal: Current opinion in oncology 20120501
Title: Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery.
Journal: Hematology reports 20120102
Title: Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.
Journal: Cancer management and research 20120101
Title: Pralatrexate (Folotyn).
Journal: Skinmed 20120101
Title: Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma.
Journal: Clinical Medicine Insights. Oncology 20120101
Title: Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Journal: European journal of haematology 20111201
Title: Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101
Title: Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii.
Journal: Clinical advances in hematology & oncology : H&O 20111101
Title: Targeted molecular therapy in peripheral T-cell lymphomas.
Journal: Expert review of hematology 20111001
Title: Peripheral T-cell lymphoma--not otherwise specified.
Journal: Critical reviews in oncology/hematology 20110901
Title: Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma.
Journal: Expert opinion on drug metabolism & toxicology 20110901
Title: Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency.
Journal: Free radical biology & medicine 20110601
Title: Hematology: relapsed and refractory PTCL--into the therapeutic abyss.
Journal: Nature reviews. Clinical oncology 20110601
Title: Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320
Title: New drug therapies in peripheral T-cell lymphoma.
Journal: Expert review of anticancer therapy 20110301
Title: Therapeutic advances in cutaneous T-cell lymphoma.
Journal: Skin therapy letter 20110201
Title: Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.
Journal: British journal of cancer 20110118
Title: Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma.
Journal: Therapeutics and clinical risk management 20110101
Title: A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
Journal: ISRN hematology 20110101
Title: An update on the management of peripheral T-cell lymphoma and emerging treatment options.
Journal: Journal of blood medicine 20110101
Title: Investigational approaches for mesothelioma.
Journal: Frontiers in oncology 20110101
Title: Targeting histone deacetyalses in the treatment of B- and T-cell malignancies.
Journal: Investigational new drugs 20101201
Title: The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.
Journal: Current opinion in investigational drugs (London, England : 2000) 20101201
Title: A case of blastic plasmacytoid dendritic cell neoplasm initially mimicking cutaneous lupus erythematosus.
Journal: Cancer research and treatment : official journal of Korean Cancer Association 20101201
Title: Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20101015
Title: Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100715
Title: Pralatrexate (Folotyn) for peripheral T-cell lymphoma.
Journal: The Medical letter on drugs and therapeutics 20100712
Title: Pralatrexate: basic understanding and clinical development.
Journal: Expert opinion on pharmacotherapy 20100701
Title: Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Journal: Oncology (Williston Park, N.Y.) 20100601
Title: New targets of therapy in T-cell lymphomas.
Journal: Current drug targets 20100401
Title: Novel agents in development for peripheral T-cell lymphoma.
Journal: Seminars in hematology 20100401
Title: Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.
Journal: Seminars in hematology 20100401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100401
Title: Anticancer agents against malaria: time to revisit?
Journal: Trends in parasitology 20100301
Title: StatBite: FDA oncology drug product approvals in 2009.
Journal: Journal of the National Cancer Institute 20100224
Title: Current and emerging treatment strategies for cutaneous T-cell lymphoma.
Journal: Drugs 20100212
Title: Pralatrexate - from bench to bedside.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100201
Title: Response to hydralazine-valproate in a patient with mycosis fungoides.
Journal: Case reports in medicine 20100101
Title: An update in management of noncutaneous T-cell lymphomas.
Journal: Advances in hematology 20100101
Title: Peripheral T-cell lymphoma: review and updates of current management strategies.
Journal: Advances in hematology 20100101
Title: Cancer chemotherapy: targeting folic acid synthesis.
Journal: Cancer management and research 20100101
Title: FDA approves pralatrexate for treatment of rare lymphoma.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101
Title: Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.
Journal: Cancer chemotherapy and pharmacology 20091001
Title: Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090910
Title: A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
Journal: Clinical pharmacology and therapeutics 20090801
Title: Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
Journal: Current opinion in hematology 20090701
Title: Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia.
Journal: Annals of surgical oncology 20090701
Title: Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Journal: Blood 20090618
Title: T-cell lymphomas.
Journal: Clinical advances in hematology & oncology : H&O 20090601
Title: Pralatrexate, a new hope for aggressive T-cell lymphomas?
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090301
Title: Optimizing chemotherapeutic strategies for peripheral T-cell lymphomas.
Journal: Clinical lymphoma & myeloma 20081201
Title: Novel therapies for cutaneous T-cell lymphomas.
Journal: Clinical lymphoma & myeloma 20081201
Title: Novel therapies in peripheral T-cell lymphomas.
Journal: Current oncology reports 20080901
Title: Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies.
Journal: IDrugs : the investigational drugs journal 20080701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080501
Title: CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Journal: Journal of the American Academy of Dermatology 20080301
Title: Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.
Journal: British journal of haematology 20071101
Title: Management of advanced-stage peripheral T-cell lymphomas.
Journal: Current hematologic malignancy reports 20071001
Title: A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070501
Title: Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20070401
Title: Pralatrexate: an emerging new agent with activity in T-cell lymphomas.
Journal: Current opinion in oncology 20061101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20061101
Title: New drugs for the treatment of advanced-stage diffuse large cell lymphomas.
Journal: Seminars in hematology 20061001
Title: A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology 20060501
Title: The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201
Title: 10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030601
Title: Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Journal: Leukemia & lymphoma 20030601
Title: Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011001
